Caraway Therapeutics
1 follower
Caraway’s therapeutic approach leverages genetic data and unique biological understanding to develop proprietary small molecules that activate cellular clearance and recycling processes – accelerating clearance of accumulated toxic materials and defective cellular components.
Org chart
Magdalene Moran
President & Chief Scientific Officer
Rhonda M. Chicko
Chief Financial Officer
Jeff Packman
Chief Development Officer
Jayhong Chong
Senior Director
